Outlook Therapeutics, Inc.
AI summary Directors and 10% shareholder buy shares in open market alongside a registered direct offering following a successful FDA dispute resolution appeal.
- Research score
- 71
- AI adjustment
- -4
Research score, not a recommendation.
Market data
Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.
–
Why this score
Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.
Why are they buying?
AI · mixed · catalyst credible · documentedInsiders and major stakeholders purchased shares immediately after the FDA granted an appeal following a Formal Dispute Resolution process for ONS-5010/LYTENAVA, concluding that substantial evidence of effectiveness had been established and clearing the path for a BLA resubmission. Concurrently, a major holder participated in a registered direct offering of common stock.
The buying cluster includes open-market purchases by multiple directors alongside a large registered direct offering by GMS Ventures (controlled by director Ghiath M. Sukhtian), supported by press releases announcing the FDA appeal win and subsequent BLA resubmission.
Stock Price & Insider Purchase History
Daily close price with open-market insider purchases plotted over time
Loading price history…
Other buying runs at OTLK
A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
After this run became a cluster: 21 days +156.9%63 days -5.0%126 days –
| Window | Insiders | Total | Score | 21 days | 63 days | 126 days | Status |
|---|---|---|---|---|---|---|---|
| 2022-09-29 → 2022-10-07 | 3 | $334.7K | 47 | -26.5% | -10.4% | -18.9% | closed |
| 2021-11-29 → 2021-12-06 | 6 | $20.2M | 76 | -4.6% | +41.4% | -19.0% | closed |
| 2021-04-19 → 2021-04-20 | 3 | $54.7K | 52 | +23.1% | +30.2% | +6.5% | closed |
| 2020-09-14 → 2020-09-22 | 3 | $20.1K | 41 | -3.4% | +85.1% | +179.7% | closed |
| 2018-12-21 → 2019-02-07 | 4 | $136.1K | 49 | +61.6% | -78.2% | -62.2% | closed |